Mennini, F. S., Paoletti, M., Bini, C., Marcellusi, A., Falcone, M., & Andreoni, M. (2022). Cost-utility analysis of ceftolozane/tazobactam vs meropenem in patients with hospital-acquired pneumonia (HABP) or ventilator-associated pneumonia (VABP). Global and Regional Health Technology Assessment, 9(1), 45–57. https://doi.org/10.33393/grhta.2022.2287